Degenerative Myelopathy in Labrador Retrievers: A Genuinely Documented Condition

Degenerative myelopathy in dogs is linked to a mutation in the SOD1 gene, and Labrador Retrievers are one of the breeds specifically included in the genetic research and DNA testing panels developed around this mutation. Carrying two copies of the mutation raises a dog's risk of eventually developing the disease, though not every genetically at-risk dog goes on to show symptoms, and onset typically doesn't occur until a dog is well into its senior years. This genetic basis is what makes DM a genuinely documented, testable condition in this breed, unlike several other neurological conditions sometimes mentioned without real evidence.

DM causes progressive weakness and loss of coordination in the hind end, starting subtly, a dragging back toe, scuffed nails, or mild wobbliness, and worsening gradually over months. Critically, this happens without pain, because the disease affects the spinal cord's nerve fibers rather than causing inflammation or nerve compression the way disc disease does. This distinction matters clinically: a dog with disc disease is often reluctant to move and shows clear pain response, while a DM-affected dog will often keep trying to move normally despite worsening coordination, precisely because nothing hurts. That contrast is frequently what helps a vet distinguish the two conditions during an exam.

If you think your Lab has degenerative myelopathy (dm), the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers hip dysplasia, elbow dysplasia, obesity.

What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.

Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for degenerative myelopathy (dm) it is often what separates a clear pattern from a guess.